Fu Ruojin, Chen Xuechen, Seum Teresa, Hoffmeister Michael, Brenner Hermann
Division of Clinical Epidemiology and Aging Research, German Cancer Research Center (DKFZ), Heidelberg 69120, Germany.
Medical Faculty Heidelberg, Heidelberg University, Heidelberg 69120, Germany.
JNCI Cancer Spectr. 2025 Mar 3;9(2). doi: 10.1093/jncics/pkaf017.
Excess alcohol consumption is associated with increased risk of colorectal cancer, but the evidence on the individual and joint effects of alcohol consumption and genetic risk on the occurrence of various stages of colorectal carcinogenesis is limited.
We evaluated the associations of alcohol consumption and a polygenic risk score based on 140 colorectal cancer related loci with findings of colorectal neoplasia among 4662 participants in the German screening colonoscopy program. Analyses were conducted by multiple logistic regression. We determined genetic risk equivalents to quantify the effect of alcohol consumption in terms of the difference in polygenic risk score conveying equivalent risk.
Moderate and high (12 to <25 g/d and ≥25 g/d) alcohol consumption was associated with increased risk of advanced colorectal neoplasia (adjusted odds ratio = 1.28, 95% CI = 1.03 to 1.58, and adjusted odds ratio = 1.44, 95% CI = 1.14 to 1.81, respectively), while associations with any colorectal neoplasia were weaker. No significant interactions between alcohol consumption and polygenic risk score were observed. Participants with high alcohol consumption in the highest polygenic risk score tertile had a 3.4-fold increased risk of advanced neoplasia compared with individuals with low or no alcohol consumption in the lowest polygenic risk score tertile. The estimated impact of high alcohol consumption on the risk of advanced neoplasia was equivalent to the risk increase by a 26-percentile-higher polygenic risk score (genetic risk equivalent = 26, 95% CI = 9 to 44).
High alcohol consumption and polygenic risk score have a major impact on the risk of advanced colorectal neoplasia. The estimated preventive impact of avoiding high alcohol consumption is as strong as the impact of having a substantially lower polygenic risk.
过量饮酒与结直肠癌风险增加有关,但关于饮酒和遗传风险对结直肠癌发生各阶段的个体及联合影响的证据有限。
我们在德国筛查结肠镜检查项目的4662名参与者中,评估了饮酒及基于140个结直肠癌相关位点的多基因风险评分与结直肠肿瘤发生情况之间的关联。通过多因素逻辑回归进行分析。我们确定了遗传风险当量,以根据传递等效风险的多基因风险评分差异来量化饮酒的影响。
中度和高度饮酒(12至<25克/天和≥25克/天)与晚期结直肠肿瘤风险增加相关(调整比值比分别为1.28,95%置信区间为1.03至1.58,以及调整比值比为1.44,95%置信区间为1.14至1.81),而与任何结直肠肿瘤的关联较弱。未观察到饮酒与多基因风险评分之间存在显著相互作用。在多基因风险评分最高三分位数中饮酒量高的参与者,与在多基因风险评分最低三分位数中饮酒量低或不饮酒的个体相比,晚期肿瘤风险增加了3.4倍。高饮酒量对晚期肿瘤风险的估计影响相当于多基因风险评分高26百分位数所增加的风险(遗传风险当量=26,95%置信区间为9至44)。
高饮酒量和多基因风险评分对晚期结直肠肿瘤风险有重大影响。避免高饮酒量的估计预防作用与多基因风险显著降低的作用一样强大。